Hangzhou Danwei Biotechnology Co., Ltd

1. the technical documentation and the EU declaration of conformity are drawn up and kept up-to-date; 2. in the case of devices for performance studies intended to be used in the context of interventional clinical performance studies or other performance studies involving risks for the subjects, the statement referred to in Section 4.1 of Annex XIV is issued.

1. the conformity of the devices is appropriately checked, in accordance with the quality management system under which the devices are manufactured, before a device is released; 2. the post-market surveillance obligations are complied with in accordance with Article 10(9); 3. the reporting obligations referred to in Articles 82 to 86 are fulfilled.